| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.5M | +0.0% |
| SG&A Expense | $22.6M | -22.8% |
| Operating Income | $4.9M | +127.6% |
| Pre-tax Income | -$17.0M | -241.2% |
| Income Tax | $11K | +413.3% |
| Net Income | -$21.2M | -281.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.2M | -35.3% |
| Total Assets | $63.7M | -11.4% |
| Total Liabilities | $3.2M | +66.1% |
| Stockholders' Equity | $60.7M | -13.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.7M | +37.1% |
| Investing Cash Flow | -$49K | -100.2% |
| Financing Cash Flow | $69K | -0.4% |